Published in Emerg Infect Dis on May 31, 2001
Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J (2002) 2.81
Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrob Agents Chemother (2003) 1.80
Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78
Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J Clin Microbiol (2005) 1.61
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis (2009) 1.60
Cryptococcal meningitis: epidemiology and therapeutic options. Clin Epidemiol (2014) 1.49
Cryptococcosis in solid organ transplant recipients: current state of the science. Clin Infect Dis (2008) 1.44
Predictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune status. PLoS One (2013) 1.23
Lipid rafts in Cryptococcus neoformans concentrate the virulence determinants phospholipase B1 and Cu/Zn superoxide dismutase. Eukaryot Cell (2006) 1.21
Identification and characterization of an SKN7 homologue in Cryptococcus neoformans. Infect Immun (2005) 1.16
Use of a suspension array for rapid identification of the varieties and genotypes of the Cryptococcus neoformans species complex. J Clin Microbiol (2005) 1.13
Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients. Clin Vaccine Immunol (2007) 1.11
The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis. J Clin Microbiol (2005) 1.01
Invasive fungal infections in solid organ transplant recipients. Future Microbiol (2012) 1.01
Invasive fungal infections after renal transplantation. Int J Organ Transplant Med (2012) 0.99
Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice. Clin Vaccine Immunol (2011) 0.98
Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice. Infect Immun (2004) 0.97
Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis (2008) 0.95
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother (2007) 0.94
Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings. Transplantation (2008) 0.92
Antifungal activity of nonantifungal drugs. Eur J Clin Microbiol Infect Dis (2003) 0.92
Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infections. Mucosal Immunol (2014) 0.90
A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins. Proteomics (2009) 0.89
Epidemiology of invasive fungal infections in the mediterranean area. Mediterr J Hematol Infect Dis (2011) 0.89
Antibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantation. Clin Vaccine Immunol (2006) 0.88
Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimens. J Clin Microbiol (2005) 0.86
Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review. BMC Infect Dis (2015) 0.86
Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models. Front Microbiol (2012) 0.86
STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice. J Immunol (2014) 0.85
Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of Cryptococcus neoformans to fluconazole. J Clin Microbiol (2004) 0.85
Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses. Proteomics (2013) 0.85
Donor transmission of Cryptococcus neoformans presenting late after renal transplantation. Clin Kidney J (2013) 0.84
STAT1 Signaling within Macrophages Is Required for Antifungal Activity against Cryptococcus neoformans. Infect Immun (2015) 0.81
Overexpression of TUF1 restores respiratory growth and fluconazole sensitivity to a Cryptococcus neoformans vad1Delta mutant. Microbiology (2010) 0.80
IL-4 receptor-alpha-dependent control of Cryptococcus neoformans in the early phase of pulmonary infection. PLoS One (2014) 0.79
A copper hyperaccumulation phenotype correlates with pathogenesis in Cryptococcus neoformans. Metallomics (2013) 0.79
Cryptococcus and Phagocytes: Complex Interactions that Influence Disease Outcome. Front Microbiol (2016) 0.79
A rare cause of cerebral venous thrombosis: cryptococcal meningoencephalitis. Neurol Sci (2016) 0.79
Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis. Transplantation (2010) 0.78
Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformans. Infect Immun (2006) 0.77
The antifungal pipeline: a reality check. Nat Rev Drug Discov (2017) 0.77
Cryptococcal panniculitis in a renal transplant recipient: case report and review of literature. J Dermatol Case Rep (2015) 0.76
Dectin-3 Is Not Required for Protection against Cryptococcus neoformans Infection. PLoS One (2017) 0.75
Diagnosis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-2). Turk J Haematol (2014) 0.75
Cryptococcal cellulitis in a heart transplant recipient. JAAD Case Rep (2016) 0.75
A Case of Disseminated Infection with Skin Manifestation Due to Non-neoformans and Non-gattii Cryptococcus in a Patient with Refractory Acute Myeloid Leukemia. Infect Chemother (2017) 0.75
Cryptococcosis in patients with hematological diseases: a 14-year retrospective clinical analysis in a Chinese tertiary hospital. BMC Infect Dis (2017) 0.75
Epidemiology of Cryptococcosis and Cryptococcal Meningitis in a Large Retrospective Cohort of Patients After Solid Organ Transplantation. Open Forum Infect Dis (2017) 0.75
Disseminated cryptococcal infection in a patient who had kidney transplant: discrepancy between clinical symptoms and microbiological findings. BMJ Case Rep (2017) 0.75
Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med (1989) 6.29
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med (1992) 5.84
Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med (1986) 5.83
Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis (2000) 3.12
Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol (1999) 2.78
TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin. J Biol Chem (1995) 2.39
Individual and environmental factors associated with infection due to Cryptococcus neoformans serotype D. French Cryptococcosis Study Group. Clin Infect Dis (1996) 2.33
Cryptococcosis. Infect Dis Clin North Am (1989) 1.87
Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. J Am Coll Surg (1996) 1.75
Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans. Mol Cell Biol (1999) 1.64
Cryptococcal disease presenting as cellulitis. Clin Infect Dis (1992) 1.63
The pulmonary lesions in cryptococcosis with special reference to subpleural nodules. Am J Clin Pathol (1954) 1.50
Fungal infection following renal transplantation. Arch Intern Med (1975) 1.48
Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A. EMBO J (1995) 1.47
Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin. Antimicrob Agents Chemother (2000) 1.42
Cryptococcosis after renal transplantation: report of ten cases. Surgery (1976) 1.41
Invasive aspergillosis in transplant recipients. Medicine (Baltimore) (1999) 1.31
High incidence of fungus infections in renal transplantation patients treated with antilymphocyte and conventional immunosuppression. Transplant Proc (1973) 1.31
Antibody response to Cryptococcus neoformans proteins in rodents and humans. Infect Immun (1999) 1.26
The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. Antimicrob Agents Chemother (1997) 1.24
Invasive fungal infections in renal transplant recipients. J Infect (1996) 1.19
Cryptococcal meningitis after liver transplantation. Transplantation (1996) 1.08
Puzzles concerning the pathogenicity of human herpesvirus 6. N Engl J Med (1993) 1.06
Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann Intern Med (2000) 1.03
Intracranial infection in cardiac transplant recipients. Ann Neurol (1981) 1.01
Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature. Medicine (Baltimore) (1996) 1.00
Acute cryptococcal cellulitis in renal transplant recipients. South Med J (1981) 0.97
Factors affecting the frequency infection in renal transplant recipients. Arch Intern Med (1976) 0.96
The neurological complications of cardiac transplantation. Brain (1976) 0.95
Successful treatment of invasive fungal infection with fluconazole in organ transplant recipients. Transplantation (1989) 0.94
Effect of uremia on lymphocyte transformation and chemiluminescence by spleen cells of normal and Cryptococcus neoformans-infected mice. Infect Immun (1981) 0.94
Cellulitis as first clinical presentation of disseminated cryptococcosis in renal transplant recipients. Scand J Infect Dis (1994) 0.93
Cryptococcal meningitis in renal transplant patients associated with environmental exposure. Transpl Infect Dis (1999) 0.92
Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy. Clin Infect Dis (2000) 0.91
Cryptococcosis in renal allograft recipients. Transplantation (1994) 0.89
Cryptococcal myositis: a case report and review of the literature. Pathology (1998) 0.89
Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. Clin Transplant (1997) 0.89
Cutaneous cryptococcosis mimicking gram-positive cellulitis in a renal transplant patient. South Med J (1981) 0.88
Infectious complications in pulmonary allograft recipients. Clin Chest Med (1990) 0.86
In vivo and in vitro studies with an atypical, rhinotropic isolate of Cryptococcus neoformans. Mycopathologia (1986) 0.85
Cryptococcosis in renal transplant recipients. Transplant Proc (1992) 0.84
Cryptococcal cellulitis with multiple sites of involvement. J Am Acad Dermatol (1987) 0.83
Cryptococcal cellulitis in a diabetic, kidney transplant patient. J Am Acad Dermatol (1994) 0.82
Survival of a patient transplanted with a kidney infected with Cryptococcus neoformans. Transplantation (1971) 0.82
Localized cutaneous cryptococcosis successfully treated with ketoconazole. J Am Acad Dermatol (1987) 0.82
Fungal infections in renal allograft recipients. Transplant Proc (1992) 0.81
Infectious complications after small bowel transplantation in adults: an update. Transplant Proc (1996) 0.80
Cryptococcal cellulitis in renal transplant recipients. J Am Acad Dermatol (1987) 0.80
Experimental cryptococcosis: dissemination of Cryptococcus neoformans and dermotropism in guinea-pigs. Mykosen (1986) 0.80
Cryptococcal meningoencephalitis as a result of long-term immunosuppression after kidney transplantation. Neuropatol Pol (1982) 0.80
Disseminated cryptococcosis presenting as cellulitis with necrotizing vasculitis. J Clin Microbiol (1986) 0.80
Cryptococcal septicemia associated with urologic instrumentation in a renal allograft recipient. J Urol (1981) 0.79
Cryptococcal pyarthrosis complicating gouty arthritis. South Med J (1989) 0.79
Cryptococcal meningoencephalitis and 5-fluorocytosine. Br Med J (1971) 0.78
Cutaneous cryptococcosis mimicking bacterial cellulitis in a liver transplant recipient: case report and review in solid organ transplant recipients. Clin Transplant (1994) 0.78
Cryptococcal arthritis after renal transplantation. South Med J (1981) 0.78
Recurrent cryptococcal choroiditis in a renal transplant patient: clinicopathologic study. Retina (1998) 0.77
Treatment of cryptococcal meningitis in liver transplantation. Infection (1999) 0.77
Cerebromeningitis in immunosuppressed recipients of renal allografts. Ann Surg (1982) 0.77
Cryptococcal meningitis causing fever of unknown origin in renal transplant recipients: report of two cases initially diagnosed by urine cultures. Transplantation (1981) 0.77
Cryptococcal pyelonephritis and disseminated cryptococcosis in a renal transplant recipient. Arch Intern Med (1981) 0.77
A case of renal transplant recipient complicated with cryptococcosis and amphotericin B induced acute tubular necrosis. Jpn Circ J (1977) 0.77
[Cryptococcosis of the skin]. Hautarzt (1989) 0.77
Cryptococcus neoformans meningitis following renal transplantation. Neth J Med (1987) 0.77
Cryptococcosis in renal transplant patients. Proc Clin Dial Transplant Forum (1977) 0.77
Successful treatment of cryptococcal meningitis with amphotericin B colloidal dispersion: report of four cases. Antimicrob Agents Chemother (1995) 0.77
Cryptococcosis after renal transplantation. Transplant Proc (1995) 0.77
Disseminated cryptococcosis presenting with a pleural effusion in a kidney transplant recipient: early diagnosis by pleural biopsy and successful treatment with oral fluconazole. Nephron (1993) 0.77
Pleural cryptococcosis. J Thorac Imaging (1990) 0.77
Cure of cryptococcemia and preservation of graft function in a renal transplant recipient. Arch Intern Med (1984) 0.77
Risk factors in necrotizing fasciitis: a case involving Cryptococcus neoformans. Ann Plast Surg (1998) 0.77
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med (2000) 23.10
A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet (1997) 10.93
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med (1996) 6.49
Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science (1997) 6.00
Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies. Infect Immun (1983) 5.85
Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med (1991) 5.85
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst (1998) 5.05
Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med (1982) 4.54
Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med (2000) 4.21
Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia. Lancet (1993) 3.89
The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med (2001) 3.39
An extremely luminous panchromatic outburst from the nucleus of a distant galaxy. Science (2011) 3.09
Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med (1991) 3.04
Comparison of health status and quality of life of related versus paid unrelated living kidney donors. Am J Transplant (2013) 3.04
Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat Genet (2000) 2.53
Effects of age on brain volume and head circumference in autism. Neurology (2002) 2.44
Genotype/Phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease. Am J Hum Genet (1999) 2.42
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect (2014) 2.13
The membrane of peroxisomes in Saccharomyces cerevisiae is impermeable to NAD(H) and acetyl-CoA under in vivo conditions. EMBO J (1995) 2.12
Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med (1996) 2.09
Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis (1999) 2.05
Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study. Ann Intern Med (2001) 1.94
Chiral symmetry breaking in sodium chlorate crystallizaton. Science (1990) 1.92
T-cell control of IL-12p75 production. Scand J Immunol (2006) 1.92
Anti-stress activity of Ocimum sanctum Linn. Indian J Med Res (1981) 1.91
Asynchronous replication and allelic exclusion in the immune system. Nature (2001) 1.89
Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center. Antimicrob Agents Chemother (1991) 1.87
Nutritive value of leaf protein from lucerne (Medicago sativa). Growth responses in rats at different protein levels & to supplementation with lysine &-or methionine. Indian J Exp Biol (1969) 1.83
Kappa chain monoallelic demethylation and the establishment of allelic exclusion. Genes Dev (1998) 1.81
Type IV collagen of the glomerular basement membrane. Evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains. J Biol Chem (2000) 1.73
Medical thoracoscopy for undiagnosed pleural effusions: experience from a tertiary care hospital in north India. Indian J Chest Dis Allied Sci (2011) 1.70
Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: a two-year outcome analysis. J Am Coll Cardiol (2001) 1.66
Adenocarcinoma of the uterine cervix compared with squamous cell carcinoma: a 12-year study in Southampton and South-west Hampshire. Cytopathology (2001) 1.62
The rod photoreceptor ATP-binding cassette transporter gene, ABCR, and retinal disease: from monogenic to multifactorial. Vision Res (1999) 1.61
Physico-chemical and pasting properties of starch from stored potato tubers. J Food Sci Technol (2010) 1.60
Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: a systematic review. Am J Transplant (2008) 1.60
Multiply antibiotic-resistant gram-negative bacilli in a long-term-care facility: a case-control study of patient risk factors and prior antibiotic use. Infect Control Hosp Epidemiol (1997) 1.60
Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med (1995) 1.59
High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial. Ann Intern Med (1994) 1.59
Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene. Invest Ophthalmol Vis Sci (2001) 1.58
Practolol in acute myocardial infarction. Acta Med Scand Suppl (1976) 1.57
Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother (1992) 1.57
Vancomycin-resistant Enterococcus faecium in a long-term care facility. J Am Geriatr Soc (1998) 1.53
Low grade gastric B-cell lymphoma of mucosa associated lymphoid tissue in immunocompromised patients. Histopathology (1996) 1.52
Cell Walls of Tobacco Cells and Changes in Composition Associated with Reduced Growth upon Adaptation to Water and Saline Stress. Plant Physiol (1989) 1.52
Monitoring of serum aminoglycoside levels with once-daily dosing. Pathology (1998) 1.50
Charcot-Leyden crystals in fine needle aspiration cytology. Acta Cytol (1997) 1.48
A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transfer. Leukemia (2007) 1.47
Beta-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease. Am J Med (1993) 1.46
Prophylactic use of gabapentin for prevention of succinylcholine-induced fasciculation and myalgia: a randomized, double-blinded, placebo-controlled study. J Postgrad Med (2012) 1.44
A multicentric study with arteether in patients of uncomplicated falciparum malaria. J Assoc Physicians India (2001) 1.44
Efficacy of various amendments for amelioration of fly-ash toxicity: growth performance and metal composition of Cassia siamea Lamk. Chemosphere (2004) 1.42
Emery-Dreifuss muscular dystrophy. Ann Neurol (1979) 1.42
Nosocomial infections in the human immunodeficiency virus-infected patient: a two-year survey. Am J Infect Control (1994) 1.42
The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg (1998) 1.42
Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. Immunol Rev (1999) 1.41
A randomized, prospective trial of stapled lung reduction versus laser bullectomy for diffuse emphysema. J Thorac Cardiovasc Surg (1996) 1.41
An outbreak of rubella in chandigarh, India. Indian Pediatr (2014) 1.40
Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients. Am J Transplant (2014) 1.40
Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only. Ann Thorac Surg (1994) 1.40
Antioxidant levels in blood and seminal plasma and their impact on sperm parameters in infertile men. Indian J Biochem Biophys (2010) 1.40
Acute onset of hematuria and proteinuria associated with multiorgan involvement of the heart, liver, pancreas, kidneys, and skin in a patient with Henoch-Schönlein purpura. Kidney Int (2007) 1.39
Antimicrobial resistance: COMs and OMFSs. Br Dent J (2016) 1.38
Juvenile muscular atrophy localized to arms. Arch Neurol (1980) 1.34
Management of extensive subcutaneous emphysema and pneumomediastinum by micro-drainage: time for a re-think? Singapore Med J (2007) 1.34
Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness. Int J STD AIDS (1999) 1.34
Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med (1999) 1.32
Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age children, 2013/14 influenza season. Euro Surveill (2014) 1.32
Allele-specific expression patterns of interleukin-2 and Pax-5 revealed by a sensitive single-cell RT-PCR analysis. Curr Biol (2000) 1.31
Invasive aspergillosis in transplant recipients. Medicine (Baltimore) (1999) 1.31
An unusual cause of respiratory distress: live leech in the larynx. Anesth Analg (2000) 1.30
Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J Biol Chem (1999) 1.30
The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome. J Biol Chem (2000) 1.29
Genital tuberculosis in Indian infertility patients. Int J Gynaecol Obstet (2007) 1.27
Bacteremia in a long-term-care facility: a five-year prospective study of 163 consecutive episodes. Clin Infect Dis (1992) 1.27
DNA integrity and semen quality in men with low seminal antioxidant levels. Mutat Res (2009) 1.26
The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood (1995) 1.26
Fungal Infections After Liver Transplantation. Transplant Proc (1988) 1.24
Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation (1997) 1.23
Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony. Parasitology (2007) 1.23
Role of AKT1 in 17beta-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells. Biochem Pharmacol (1999) 1.23
Confounding experimental considerations in nanogenotoxicology. Mutagenesis (2009) 1.19
Growth of 28 Legionella species on selective culture media: a comparative study. J Clin Microbiol (1993) 1.19
Calorimetric methods for interpreting protein-ligand interactions. Methods Enzymol (1995) 1.16
Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas. Br J Cancer (2002) 1.16
Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis. Clin Infect Dis (1999) 1.15
Effect of cement dust on the growth and yield of Brassica campestris L. Environ Pollut (1990) 1.15
Modulation of voltage-dependent Ca2+ channels in rabbit colonic smooth muscle cells by c-Src and focal adhesion kinase. J Biol Chem (1998) 1.14
Is the patient brain-dead? Emerg Med J (2006) 1.13
A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res (1996) 1.13
Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages. J Immunol (1995) 1.13
Chemopreventive activity of Withania somnifera in experimentally induced fibrosarcoma tumours in Swiss albino mice. Phytother Res (2001) 1.13
Evaluation of a rapid test for the detection of antibodies to human immunodeficiency virus type 1 and 2. Int J STD AIDS (1999) 1.12
Differential expressions of bilaterally unerupted supernumerary teeth. J Indian Soc Pedod Prev Dent (2011) 1.12
Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation (2000) 1.11